口服抗凝药联用阿司匹林的出血风险:系统评价与荟萃分析
该系统评价与荟萃分析纳入42项研究,比较口服抗凝药(OAC)联用阿司匹林与单用OAC或单用阿司匹林的任何类型出血风险。结果显示,与单用OAC相比,联用阿司匹林在随机对照试验(OR 1.36,95%CI 1.15-1.59)和观察性研究(OR 1.42,95%CI 1.09-1.87)中均显著增加出血风险;与单用阿司匹林相比,随机对照试验显示联用组出血率更高(OR 2.36,95%CI 1.91-2.92),观察性研究无显著差异(OR 1.93,95%CI 0.99-3.75)。
要点
- OAC联用阿司匹林较单用OAC显著增加任何类型出血风险。
- 随机对照试验显示联用阿司匹林较单用阿司匹林出血风险更高。
- 临床应审慎评估OAC与阿司匹林联用的必要性及出血风险。
核心结论
- 与单用OAC相比,联用阿司匹林在随机对照试验和观察性研究中均显著增加任何类型出血风险。
- 随机对照试验比较OAC联用阿司匹林与单用阿司匹林,提示联用组出血风险亦增加。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE和Web of Science(2021年1月),纳入随机对照试验或观察性研究,共42项研究。
- 采用随机效应模型计算合并比值比(OR)。
主要发现
- OAC联用阿司匹林对比单用OAC:15项随机对照试验的OR为1.36(95%CI 1.15-1.59),19项观察性研究的OR为1.42(95%CI 1.09-1.87)。
- OAC联用阿司匹林对比单用阿司匹林:15项随机对照试验的OR为2.36(95%CI 1.91-2.92),10项观察性研究的OR为1.93(95%CI 0.99-3.75),观察性研究无显著差异。
临床怎么用
- 临床在考虑OAC与阿司匹林联用时,应评估出血风险,仅在明确获益时联用。
- 对已联用OAC和阿司匹林的患者,需加强出血监测与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oral anticoagulants (OACs) and aspirin can trigger bleeding events when used alone or in combination. The purpose of this study was to compare the risk of any type of bleeding in individuals exposed to a combination of OAC and aspirin with the risk in those taking an OAC or aspirin alone. METHODS: MEDLINE and Web of Science were queried in January 2021 for eligible articles. Studies were included if they were either randomized controlled trials (RCTs) or observational studies and evaluated the number of any bleeding events in two groups, one with exposure to both OAC and aspirin and one with exposure to OAC alone or aspirin alone. Pooled odds ratios were calculated using a random-effects model. RESULTS: Forty-two studies were included. In an analysis of 15 RCTs and 19 observational studies evaluating OAC plus aspirin versus OAC alone, a significant difference in the risk of bleeding was observed in the combination groups, with an odds ratio [OR] of, 1.36 (95% CI, 1.15-1.59) for RCTs and an OR of 1.42 (95% CI-, 1.09-1.87) for observational studies. When OAC plus aspirin was compared to aspirin alone, a higher rate of bleeding was found in the combination group (OR, 2.36; 95%CI, 1.91-2.92) in the analysis of 15 RCTs, but no significant difference was found among 10 observational studies (OR, 1.93; 95% Cl, 0.99-3.75). CONCLUSION: The risk of any type of bleeding was significantly increased among patients taking aspirin plus OAC compared to those taking OAC alone in both RCTs and observational studies. Evaluation of RCTs comparing OAC plus aspirin to aspirin alone suggests increased bleeding risk as well.
引用
- Ghule P, Panic J, Malone DC, et al. Risk of bleeding with concomitant use of oral anticoagulants and aspirin: A systematic review and meta-analysis. Am J Health Syst Pharm. 2024. PMID: 38263263. doi:10.1093/ajhp/zxae010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。